Author

Gwendoline Peyratout

Centre Hospitalier Universitaire Vaudois

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2 Genomics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:GWAS / association mapping· 3 Approach:statistical model· 3 Assay:GWAS summary statistics· 2 Assay:bulk RNA-seq· 1 Assay:DNA methylation· 1 Approach:machine learning (classical)· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Alberto LleóiD· 4 shared André FrankeiD· 4 shared Charlotte Elisabeth TeunisseniD· 4 shared Giovanni Battista FrisoniiD· 4 shared Henrik ZetterbergiD· 4 shared Jill C. RichardsoniD· 4 shared Johannes Rolf StrefferiD· 4 shared Julius PoppiD· 4 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersGenetic & Genomic Medicine

Alberto LleóORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Blood-based multivariate methylation risk score for cognitive impairment and dementia

Jarno Koetsier, Rachel Cavill, Rick A. Reijnders, Joshua Harvey, Jan Homann, Morteza P Kouhsar, Kay Deckers, Sebastian Köhler, Lars Eijssen, Daniël van den Hove, Ilja Demuth, Sandra Düzel, Alzheimer’s Disease Neuroimaging Initiative, Rebecca G. Smith, Adam R. Smith, , Ehsan Pishva

The paper develops a multivariate methylation risk score using blood DNA methylation data to predict dementia risk and cognitive impairment in Alzheimer's and Parkinson's disease cohorts.

Alzheimer s & Dementia · Aug 28, 2024Peer-reviewedGenetic & Genomic Medicine

Genome-wide association study of Alzheimer's disease brain imaging biomarkers and neuropsychological phenotypes in the EMIF-AD Multimodal Biomarker Discovery dataset

Jan Homann, Tim Osburg, Olena Ohlei, Valerija Dobričić, Laura Deecke, Isabelle Bos, Rik R. Vandenberghe, Silvy Gabel, Philip Scheltens, Charlotte Elisabeth Teunissen, Sebastiaan Engelborghs, Giovanni Battista Frisoni, Olivier J. Blin, Jill C. Richardson, Régis Bordet, , Lars Bertram

This study performs GWAS on quantitative AD biomarkers and cognitive traits, identifying new loci associated with memory performance and cognitive decline.

Frontiers in Aging Neuroscience · Mar 21, 2022Peer-reviewedGenetic & Genomic Medicine

TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels

Shengjun Hong, Valerija Dobričić, Olena Ohlei, Isabelle Bos, Stephanie J. B. Vos, Dmitry Prokopenko, Betty Marije Tijms, Ulf Andréasson, Kaj Blennow, Rik R. Vandenberghe, Silvy Gabel, Philip Scheltens, Charlotte Elisabeth Teunissen, Sebastiaan Engelborghs, Giovanni Battista Frisoni, , Lars Bertram

The paper conducts GWAS on CSF Alzheimer's disease biomarkers, identifying genetic associations with NF-L, YKL-40, and Ng levels.

Alzheimer s & Dementia · May 14, 2021Peer-reviewedGenomics

Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

Shengjun Hong, Dmitry Prokopenko, Valerija Dobričić, Fabian Kilpert, Isabelle Bos, Stephanie J. B. Vos, Betty Marije Tijms, Ulf Andréasson, Kaj Blennow, Rik R. Vandenberghe, Isabelle Cleynen, Silvy Gabel, Jolien M. Schaeverbeke, Philip Scheltens, Charlotte Elisabeth Teunissen, , Lars Bertram

The paper conducts a genome-wide association study (GWAS) on Alzheimer’s disease CSF biomarkers in the EMIF-AD dataset, identifying novel genetic signals and confirming existing associations.

Translational Psychiatry · Nov 22, 2020Peer-reviewedGenomics